10 Best Brain-Computer Interface Stocks to Buy
In this article, we will discuss: 10 Best Brain-Computer Interface Stocks to Buy.
Neuropace Inc (NPCE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polar Capital Brian Ashford-Russell And Tim Woolley | 3,298,104 | $52,406,873 | 0.12% | |
| 2. | Soleus Capital Guy Levy | 2,911,122 | $46,257,729 | -1% | 1.59% |
| 3. | OrbiMed Advisors Samuel Isaly | 1,505,125 | $23,916,436 | -29% | 0.44% |
| 4. | Driehaus Capital Richard Driehaus | 1,447,391 | $22,999,043 | -1% | 0.13% |
| 5. | Armistice Capital Steven Boyd | 692,000 | $10,995,880 | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 62,398 | $93,534.60 | 4,432,948 | 2022-11-22 | Filing | |
| $1.50 | 327,893 | $491,511.61 | 4,370,550 | 2022-11-21 | Filing | |
| $17.00 | 235,000 | $3,995,000.00 | 235,000 | 2021-04-21 | Filing | |
| $17.00 | 2,352 | $39,984.00 | 2,352 | 2021-04-21 | Filing | |
| $17.00 | 588,235 | $9,999,995.00 | 588,235 | 2021-04-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.97 | 25,000 | $399,250.00 | 49,964 | 2025-12-15 | Filing | |
| $15.94 | 34,000 | $541,960.00 | 3,238,199 | 2025-05-14 | Filing | |
| $15.83 | 134,136 | $2,123,372.88 | 3,272,199 | 2025-05-14 | Filing | |
| $13.72 | 78,334 | $1,074,844.31 | 81,993 | 2025-02-21 | Filing | |
| $9.40 | 5,270,845 | $49,545,943.00 | 0 | 2025-02-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12 | $165 | 0% | |
| 2. | 3 | $41 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2026 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2026 Earnings Call Transcript May 12, 2026NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.13192, expectations were $-0.19.
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2025 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2025 Earnings Call Transcript November 4, 2025NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.2.
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2025 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2025 Earnings Call Transcript August 12, 2025NeuroPace, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.24.
NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey
NeuroPace, Inc. (NASDAQ:NPCE) is among the best NASDAQ stocks under $50 to buy. Cantor Fitzgerald reiterated its Overweight rating on NeuroPace, Inc.
10 Best NASDAQ Stocks Under $50 to Buy
In this article, we will take a look at some of the best NASDAQ stocks under $50 to buy.
H.C. Wainwright Initiates Coverage of NeuroPace (NPCE) With Buy Rating
On May 28, H.C. Wainwright analyst Yi Chen initiated coverage of NeuroPace, Inc. (NASDAQ:NPCE) with a Buy rating and a price target of $18.
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2025 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2025 Earnings Call Transcript May 13, 2025NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.26.
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2024 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2024 Earnings Call Transcript March 4, 2025NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.25.
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2024 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2024 Earnings Call Transcript November 12, 2024NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.27.
Hedge Fund Resource Center